78 related articles for article (PubMed ID: 20345766)
1. Pre-synaptic glutamate-induced activation of DA release in the striatum after partial nigral lesion.
Dzahini K; Dentresangle C; Le Cavorsin M; Bertrand A; Detraz I; Savasta M; Leviel V
J Neurochem; 2010 Jun; 113(6):1459-70. PubMed ID: 20345766
[TBL] [Abstract][Full Text] [Related]
2. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
[TBL] [Abstract][Full Text] [Related]
3. Effect of AdGDNF on dopaminergic neurotransmission in the striatum of 6-OHDA-treated rats.
Smith AD; Kozlowski DA; Bohn MC; Zigmond MJ
Exp Neurol; 2005 Jun; 193(2):420-6. PubMed ID: 15869944
[TBL] [Abstract][Full Text] [Related]
4. Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine.
Moroz IA; Peciña S; Schallert T; Stewart J
Exp Neurol; 2004 Sep; 189(1):78-93. PubMed ID: 15296838
[TBL] [Abstract][Full Text] [Related]
5. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
[TBL] [Abstract][Full Text] [Related]
6. Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine.
Meissner W; Ravenscroft P; Reese R; Harnack D; Morgenstern R; Kupsch A; Klitgaard H; Bioulac B; Gross CE; Bezard E; Boraud T
Neurobiol Dis; 2006 Jun; 22(3):586-98. PubMed ID: 16531050
[TBL] [Abstract][Full Text] [Related]
7. Striatal interaction among dopamine, glutamate and ascorbate.
Morales I; Fuentes A; Ballaz S; Obeso JA; Rodriguez M
Neuropharmacology; 2012 Dec; 63(8):1308-14. PubMed ID: 22959966
[TBL] [Abstract][Full Text] [Related]
8. Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease.
Lin L; Meng T; Liu T; Zheng Z
Life Sci; 2013 Mar; 92(4-5):311-6. PubMed ID: 23333823
[TBL] [Abstract][Full Text] [Related]
9. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats.
Buck K; Ferger B
Neurobiol Dis; 2008 Feb; 29(2):210-20. PubMed ID: 17920284
[TBL] [Abstract][Full Text] [Related]
10. Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum.
Leng A; Feldon J; Ferger B
Synapse; 2003 Dec; 50(3):240-50. PubMed ID: 14515342
[TBL] [Abstract][Full Text] [Related]
11. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
Konieczny J; Lenda T; Czarnecka A
Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
[TBL] [Abstract][Full Text] [Related]
12. CGP 56999A, a GABA(B) receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway.
Enna SJ; Reisman SA; Stanford JA
Neurosci Lett; 2006 Oct; 406(1-2):102-6. PubMed ID: 16890350
[TBL] [Abstract][Full Text] [Related]
13. Chronic nicotine treatment differentially regulates substance P and tyrosine hydroxylase immunoreactivity in substantia nigra ipsilateral to a unilateral lesion.
Janson AM; Fuxe K
Exp Neurol; 1997 Aug; 146(2):575-86. PubMed ID: 9270071
[TBL] [Abstract][Full Text] [Related]
14. Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors.
Andersson DR; Björnsson E; Bergquist F; Nissbrandt H
Exp Neurol; 2010 Jan; 221(1):251-9. PubMed ID: 19944096
[TBL] [Abstract][Full Text] [Related]
15. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
[TBL] [Abstract][Full Text] [Related]
16. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
[TBL] [Abstract][Full Text] [Related]
18. Different levodopa actions on the extracellular dopamine pools in the rat striatum.
Rodríguez M; Morales I; González-Mora JL; Gómez I; Sabaté M; Dopico JG; Rodríguez-Oroz MC; Obeso JA
Synapse; 2007 Feb; 61(2):61-71. PubMed ID: 17117421
[TBL] [Abstract][Full Text] [Related]
19. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
20. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
